Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis

Clinical Infectious Diseases

Volumn 18, Issue 4, 1994, Pages 525-532

  Guiot, H F L ^a   Fibbe, W E ^a   Van't Wout J W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ACTINOMYCES; ADULT; ARTICLE; ASPERGILLUS; BACTEREMIA; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANDIDA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTOPENIA; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; MALE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; BACTEREMIA; BONE MARROW TRANSPLANTATION; CANDIDIASIS; FEMALE; GRAFT VS HOST DISEASE; HUMAN; LEUKEMIA; MALE; MIDDLE AGE; MYCOSES; OPPORTUNISTIC INFECTIONS; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 0028258678     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/18.4.525     Document Type: Article

References (31)

1. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 published cases. Rev Infect Dis 1990;12:1147-201.
2. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-11.
3. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86:668-72.
4. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
5. Tricot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G. Ketoconazolc vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis 1987;9(suppl l):S94-9.
6. Guiot HFL, van den Broek PJ, van der Meer JWM, van Furth R. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J Infect Dis 1983;147:615-23.
7. Guiot HFL, van Furth R. Selective decontamination in bone marrow transplant recipients. Epidemiol Infect 1992;109:349-60.
8. Guiot HFL, Helmig-Schurter AV, van der Meer JWM, van Furth R. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures. Scand J Infect Dis 1986;18:153-60.
9. Guiot HFL, Helmig-Schurter AV, van’t Noordende JM. The relevance of cultures of catheter-drawn blood and heparin-lock fluid to diagnose infection in hematologic patients. Ann Hematol 1992;64:28-34.
10. Foerster J. Bone marrow transplantation. In: LeeGR, Bithell TC, Foer-ster J, Athens JW, Lukens JN, eds. Wintrobe’s clinical hematology. 9th ed. Vol 1. Philadelphia and London: Lea &Febiger, 1993:701 — 11.
11. DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA. Fungal infections in patients with acute leukemia. Am J Med 1992;73:543-8.
12. Pirsch JD, Maki DG. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow: increased susceptibility to fungal infections. Ann Intern Med 1986;104:619-31.
13. Jeffery GM, Beard MEJ, Ikram RB, et al. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am J Med 1991;90:685-92.
14. Meunier F, Klastersky J. Recent developments in prophylaxis and therapy of invasive fungal infections in granulocytopenic cancer patients. Eur J Cancer Clin Oncol 1988;24:539-44.
15. Powles RL, Milliken S. The prophylaxis of fungal infections. J Antimi-crob Chemother 1991;28(suppl A):97-103.
16. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379-90.
17. Guiot HFL, Peters WG, van den Broek PJ, et al. Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 1990; 18: 131-7.
18. Guiot HFL, van der Meer JWM, van den Broek PJ, Willemze R, van Furth R. Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole. Ann Hematol 1992;64: 260-5.
19. Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 1992;165:891-7.
20. van’t Wout JW, Novakova I, Verhagen CAH, Fibbe WE, de Pauw BE, van der Meer JWM. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J Infect 1992;22:45-52.
21. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-70.
22. Meunier F. Prevention of mycoses in immunocompromised patients. Rev Infect Dis 1987;9:408-16.
23. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990;161:381-96.
24. Guiot HFL. Colonisation resistance and the use of antimicrobial agents for prophylaxis and therapy. Rev Med Microbiol 1991;2:194-9.
25. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Sarai R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274—7.
26. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida krusei fungemia [letter]. N Engl J Med 1991;325:1315.
27. Peterson PK, McGlave P, Ramsay NK.C, et al. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect Control 1983;4:81-9.
28. Meyers JD, Thomas ED. Infection complicating bone marrow transplantation. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. New York: Plenum Press, 1981:50751.
29. Rotstein C, Cummings KM, Tidings J, et al. An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study. Infect Control 1985;6:347-55.
30. Milliken ST, Powles RL. Antifungal prophylaxis in bone marrow transplantation. Rev Infect Dis 1990;12(suppl 3):S374-9.
31. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990;17(suppl 6): 10-3.